IFI-M · AB Flux-Balanced Series

Specimen SS-F-M2-07062 // MULTI-AXIS · IFI-M

AB Flux-Balanced Series IV-BL-C

Vitis vinifera

Grape

Tier IVAB Flux-Balanced Series

Target Trait

4.19×

fold-change

Astringency+Bitter-Attenuation flux-balanced output

Technical Specifications

SKU

SS-F-M2-07062

Genomic Edits

12

GC Content

43.8%

Construct Length

5,938 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

Polyphenol-astringency axis + TAS2R38 (suppression)

IFI Score

419

Pathway Edits

  • Polyphenol-astringency axis pathway primary gene cluster overexpression for astringency axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized A+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-A and IFI-B pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Astringency-Bitter-Attenuation combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for A+B simultaneous accumulation
  • Cofactor balance optimization for A+B dual-pathway operation
  • Protein scaffold engineering for A+B enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized Polyphenol-astringency axis and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous astringency and bitter-attenuation accumulation without competing pathway suppressionFlux-balanced gene dosing for AB multi-axis integrationBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV AB dual-axis flux-balanced platform for food ingredient applications requiring verified combined astringency+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$4149 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities